Stay on top of the health stories that matter most.
50 articles
A large NHS study found a multi-cancer blood test missed its main goal, yet still caught 16% more early-stage cancers and cut emergency diagnoses by 25%.
Almonds cut anemia risk by 80 percent in aging mice, a new study finds, suggesting a simple dietary change could protect blood health in older adults.
Trauma patients in the ICU show immune overactivity, not exhaustion, a finding that could help doctors identify high-risk patients within days of.
Heavy drinking may speed up brain aging and raise Alzheimer's risk, but experts say cutting back could meaningfully lower your dementia risk.
Canada has roughly 800 dermatologists for 38 million people, leaving skin cancer patients waiting months while Botox appointments open within days.
People with chronic illness build flu vaccine immunity just as strong as healthy adults, a new Australian study of 300+ participants confirms.
A cancer drug called teclistamab helped 11 of 18 patients with severe, treatment-resistant autoimmune diseases, offering hope where standard therapies had.
A new colorectal cancer drug combination improved survival to 10.9 months versus 9.4, but showed no significant benefit for patients without liver.
Traffic noise raises heart disease risk for 90% of NYC residents, with a new study linking road noise to 7.5% higher cardiovascular event risk.
Federal health officials plan to update testosterone therapy labels, dropping most prostate cancer restrictions after a 5,200-man trial found no added.
Personalized melanoma vaccines paired with immunotherapy are pushing survival rates from below 10% to nearly 40%, but equitable access remains a critical.
Blood sugar below 55 mg/dL can cause seizures or coma, while levels above 600 mg/dL signal a life-threatening emergency every diabetic should recognize.
New research finds flu vaccines trigger different immune responses by age, with high-dose options best for older adults and cell-based vaccines for.
Two patients with severe autoimmune disease stayed symptom-free for 15 years after immune system replacement, with no medication needed.
A new clinical trial found omega-3 fish oil supplements alone won't protect your brain; they only work when paired with a healthy lifestyle.
Older adults with dementia, stroke, or Parkinson's disease face triple the traumatic brain injury risk, making early fall screening critical after.
Teen football players with concussions face more than double the risk of high blood pressure, a finding that reshapes how head injuries in young athletes.
Parents trained in autism strategies can help children build social communication skills, even with fewer sessions than traditional therapy requires.
Breast cancer survivors face 17% higher cancer risk, but a new study finds annual multicancer blood tests could prevent hundreds of late-stage diagnoses.
Lifestyle changes cut chronic disease risk by 21% in prediabetes patients, outperforming metformin across a landmark 21-year study.
GLP-1 drugs are transforming PCOS treatment by targeting insulin resistance, the root cause of the condition now renamed PMOS by The Lancet in 2026.
Unexplained bone fractures may signal systemic mastocytosis, a rare immune disorder doctors often miss until a simple tryptase blood test reveals the.
Scientists found that blocking a protein called DHHC3 in melanoma cells triggers a powerful immune attack, shrinking tumors in animal models.
Setting a weight loss goal before starting Zepbound led to significantly better results, a study of 81,000 people found.
Retatrutide, a new weight-loss drug, helped trial participants lose 30% of their body weight, surpassing Ozempic and matching bariatric surgery results.
Only 22% of stroke patients receive inpatient rehabilitation after hospitalization, and Black patients face a 29% higher chance of being sent home instead.
Daraxonrasib targets KRAS, mutated in 90% of pancreatic cancers, offering new hope for patients who have exhausted standard treatments.
A minimally invasive knee procedure called genicular artery embolization cut pain scores in half, with 80% of patients seeing lasting relief at 12 months.
Glucosamine, a popular joint supplement taken by millions, may raise mortality risk by 25 percent in people already diagnosed with dementia, researchers.
An AI-designed vaccine trained the immune system to recognize entire coronavirus families, marking a shift from reactive to pandemic-proof protection.
A Canadian trial will test whether tirzepatide can help type 1 diabetes patients achieve fully automated insulin control without counting carbs.
Blast-induced brain injuries can silently raise stroke risk years later, yet often show nothing on standard scans, researchers warn.
Researchers identified stem-like CD8+ T cells that drive kidney damage in lupus nephritis through a specific immune activation pathway, revealing new.
People taking Ozempic and Wegovy are walking 560 fewer steps daily after starting treatment, and experts say exercise must be part of any weight loss drug.
Teens with traumatic brain injuries face 30% higher rates of depression and anxiety years later, requiring long-term mental health monitoring.
Sunscreen misinformation on social media is driving UK melanoma cases to record highs, with 86% of over 20,000 annual cases being preventable.
New breast cancer research shows 68% of early-stage patients may skip chemotherapy safely, while new drug combos extend metastatic survival by years.
Children's well-being declined in 29 states from 2019 to 2024, with national scores dropping as health and education challenges offset gains in poverty.
Healthy college students wearing glucose monitors discovered surprising blood sugar spikes from stress and specific foods, leading to lasting diet changes.
Young men are turning to unproven "spermmaxxing" trends like testicle tanning despite sperm counts dropping 50% in recent decades.
You can get breast and cervical cancer screening without a doctor through self-referral programs, community clinics, and health departments.
New drug combination cuts prostate cancer progression risk by 52% while pre-surgery treatment boosts survival odds in breakthrough trials.
Returning baby reflexes in healthy older adults may signal nearly double the dementia risk within seven years, a 19-year study of 870+ people found.
A new oral GLP-1 pill for type 2 diabetes helped 72% of patients lose weight, offering hope for the 30% of adults who avoid shots due to needle fear.
Immunotherapy for melanoma achieves 60% response rates but can cause life-threatening side effects requiring careful monitoring and specialist care.
Dementia care costs exceed $750,000 per family, but early financial planning and brain-healthy lifestyle changes can help reduce this devastating burden.
Apnimed's experimental oral medication AD109 shows promise as the first pill designed to treat obstructive sleep apnea by targeting its root cause, with.
Canadian scientists are racing to become the first to diagnose CTE in living patients, potentially saving thousands from a brain disease currently only.
GLP-1 drugs like Zepbound now treat sleep apnea by targeting weight loss, with patients reducing breathing interruptions by up to 50%.
New Mayo Clinic research reveals Alzheimer's brain changes accelerate in your late 50s, decades before memory loss appears, reshaping early detection.
